MedTrace Logo

Gastric Cancer Registry for Epidemiology and Molecular Risk Factor

NCT03046745 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2020-05-19

No results posted yet for this study

Summary

This study is a multi-center, prospective cohort study which are planned to enroll the 2,500 patients who diagnosed the primary gastric cancer and 5,000 healthy normal cohort participants for 5 years. All participants who enrolled in this registry, the participants were questioned by the gastric cancer survey and the serum and tissue of these participants were analyzed.

The main aim of this study is

1. To evaluate the optimal interval of endoscopic screening for early detection of gastric cancer and risk factors in Korean.
2. To evaluate the diagnostic validity of serum biomarker (combining pepsinogen, H pylori IgG Antibody, and TFF3) as a screening test for detection of GC in Korean.

Conditions

Sponsors & Collaborators

  • Ministry of Health & Welfare, Korea

    collaborator OTHER_GOV

  • Kyungpook National University Hospital

    lead OTHER

Principal Investigators

  • Seong Woo Jeon, Professor · Gastric Cancer Center, Kyungpook National University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2021-04-30
Completion
2022-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046745 on ClinicalTrials.gov